Christina Sampaio

TL;DR: Clinical diagnostic criteria for probable and possible PD‐D are proposed, characterized by impairment in attention, memory, executive and visuo‐spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent.

TL;DR: Treatment strategies that provide more continuous stimulation of dopamine receptors provide reduced motor complications in MPTP monkeys and PD patients and studies raise the possibility that more continuous and physiological delivery of levodopa might reduce the risk of motor complications.

TL;DR: A systematic literature review was conducted to identify scales that have either been validated or used in PD patients and found the Snaith‐Hamilton Pleasure Scale (SHAPS) and the Chapman scales for physical and social anhedonia.

TL;DR: A systematic review of anxiety scales used in patients with Parkinson's disease found that several scales exist and have been used in PD are inadequate, and development of a new scale to assess anxiety in PD should be considered.

TL;DR: The proportions of costs components of PD vary notably; variations were due to differences in country-specific health system characteristics, macro economic conditions, as well as frequencies of resource use and price differences.